Corcept officer buys 328 shares, 91 withheld for tax
Corcept Therapeutics’ chief business officer reported small equity grants, a tax withholding share disposition, and indirect trust and custodial holdings.
Rhea-AI Filing Summary
CORCEPT THERAPEUTICS INC (CORT) reported insider equity activity by Chief Business Officer Gary Charles Robb. On September 1, 2026, he acquired 164 shares of common stock through a purchase plan and a further 164 shares underlying restricted stock awards, which vest after one year if specified conditions are met. On September 2, 2026, 91 shares were withheld by the company to satisfy tax withholding obligations upon vesting of restricted stock units. He also reports indirect ownership of 39,716 shares held in a revocable trust, plus additional shares in custodial accounts for his children.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F5, F6, F7 | 91 | $113.38 | $10K |
| Grant/Award | Common Stock F1, F2, F3 | 164 | $113.38 | $19K |
| Grant/Award | Common Stock F4, F3 | 164 | $0.00 | $0.00 |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
| holding | Common Stock F10 | -- | -- | -- |
Footnotes (10)
- F1. The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026.
- F2. In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- F3. Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F4. Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
- F5. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- F6. The closing price on September 1, 2026 was used to calculate the withholding obligation.
- F7. Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F8. These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
- F9. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- F10. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Key Figures
Key Terms
restricted stock awards financial
restricted stock units financial
Uniform Transfers to Minors Act regulatory
Incentive Award Plan financial
FAQ
What insider transactions did CORT’s Chief Business Officer report on this Form 4?
What are the vesting terms of the new restricted stock awards at CORT?
What indirect holdings of Corcept Therapeutics (CORT) stock does the insider report?
Were the reported CORT transactions made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.